Jill Milne

Director/Board Member at BIOCRYST PHARMACEUTICALS, INC.

Net worth: 284 568 $ as of 2026-05-30

58 year

70 connections

Health Technology

Consumer Services

Finance

Profile

Jill C.
Milne was the founder of Astria Therapeutics, Inc., founded in 2008, where the titles held included President, Chief Executive Officer & Director from 2019 to 2026.
Dr. Milne currently serves as a Director at BioCryst Pharmaceuticals, Inc., starting in 2026.
Former jobs include Head-Enzyme Target Group at Pfizer Inc., Head-Discovery Biology at Sirtris Pharmaceuticals, Inc. from 2004 to 2008, Principal at Polaris Growth Management LLC, and Head-Worldwide Drug Pfinder Program at Pfizer (St. Louis) from 1998 to 2004.
Education includes a doctorate from Harvard University and an undergraduate degree from Wellesley College.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BIOCRYST PHARMACEUTICALS, INC. 0.01%	2026-06-10	31,938 ( 0.01% )	284 568 $	2026-05-30

Jill Milne active positions

Companies	Position	Start
BIOCRYST PHARMACEUTICALS, INC.	Director/Board Member	2026-01-22

All active positions of Jill Milne

Former positions of Jill Milne

Companies	Position	End
ASTRIA THERAPEUTICS, INC.	Chief Executive Officer	2026-01-22
Sirtris Pharmaceuticals, Inc. Sirtris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs and pharmaceuticals	Corporate Officer/Principal	2007-12-31
Pfizer (St. Louis) Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals	Corporate Officer/Principal	2003-12-31
PFIZER INC.	Corporate Officer/Principal	-
Polaris Growth Management LLC Polaris Growth Management LLC Investment ManagersFinance Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies. The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software. In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services. Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services. Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs.	Corporate Officer/Principal	-

See the detail of Jill Milne's experience

Training of Jill Milne

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jill Milne's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
BioCryst Pharmaceuticals, Inc. BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics	Health Technology
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
Sirtris Pharmaceuticals, Inc. Sirtris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs and pharmaceuticals	Health Technology
Astria Therapeutics, Inc. Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases	Health Technology
Polaris Growth Management LLC Polaris Growth Management LLC Investment ManagersFinance Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies. The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software. In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services. Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services. Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs.	Finance
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Wellesley College Wellesley College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Pfizer (St. Louis) Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals	Health Technology